SavedAdd your journal

Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 5

Impact of the Novel Coronavirus Disease 2019(COVID-19) Pandemic on Cardiac Emergencies andFuture Perspectives in Turkey

Afşin Emre KAYIPMAZ
Ali ÇONER
Elif ÇELİKEL
Pages
419–422
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this narrative review, we aimed to discuss the cardiac manifestations of COVID-19, the possible druginteractions related to the drugs used for COVID-19 management, and the effect of the pandemic on cardiac emergencies.We believe that understanding the natural mechanism of cardiac involvement of SARS-CoV-2 and emphasizing the dataabout out-of-hospital arrests will help clinicians effectively deal with the preventable cardiovascular causes of death in theforthcoming waves of COVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:SARS-CoV-2-associated COVID-19 pandemic has affected the daily life of people across the world in 2020.
📊
Key Findings & Data:COVID-19 is a multi-systemic disease, and the clinical pre sentations and possible complications may vary widely in different patient groups.
💡
Conclusion & Impact:In this narrative review, we aimed to discuss the cardiac manifestations of COVID-19, the possible druginteractions related to the drugs used for COVID-19 management, and the effect of the pandemic on cardiac emergencies.We believe that understanding the natural mechanism of cardiac involvement of SARS-CoV-2 and emphasizing the dataabout out-of-hospital arrests will help clinicians effectively deal with the preventable cardiovascular causes of death in theforthcoming waves of COVID-19.
🔬Design:Review & Systematic Survey
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

SARS-CoV-2-associated COVID-19 pandemic has affected the daily life of people across the world in 2020. Data aboutthe course of viral involvement continues to be accumulated. COVID-19 is a multi-systemic disease, and the clinical pre sentations and possible complications may vary widely in different patient groups. The cardiovascular system is a primarytarget of COVID-19, and direct or indirect effects of viral involvement are observed. In addition to the direct effects of viralinvolvement on the cardiovascular system, decrement in acute cardiac emergencies has been experienced in many cardi ology clinics in Turkey during the pandemic. Moreover, there may be a possible increase in out-of-hospital cardiac arrestsin the near future. In this narrative review, we aimed to discuss the cardiac manifestations of COVID-19, the possible druginteractions related to the drugs used for COVID-19 management, and the effect of the pandemic on cardiac emergencies.We believe that understanding the natural mechanism of cardiac involvement of SARS-CoV-2 and emphasizing the dataabout out-of-hospital arrests will help clinicians effectively deal with the preventable cardiovascular causes of death in theforthcoming waves of COVID-19.

🔖

Cite This Article

KAYIPMAZ, A. E., ÇONER, A., ÇELİKEL, E. (2022). Impact of the Novel Coronavirus Disease 2019(COVID-19) Pandemic on Cardiac Emergencies andFuture Perspectives in Turkey. Erciyes Medical Journal, Cilt: 43 - Sayı: 5, 419–422. https://ajindex.com/articles/502298

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Topol EJ. COVID-19 can affect the heart. Science 2020; 370(6515): 408–9
  2. Ministry of Health of Turkey. Current status in Turkey 2020. Available from: URL: https://covid19.saglik.gov.tr. Accessed Dec 20, 2020
  3. Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 2020; 141(23): 1903–14
  4. Şimşek Yavuz S. Cardiovascular system and COVID-19. [Article in Turkish]. Turk Kardiyol Dern Ars 2020; 48(7): 635–9
  5. Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, et al. The heart and COVID-19: What cardiologists need to know. Arq Bras Cardiol 2020; 114(5): 805–16
  6. Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung SH, et al. The COVID-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med 2020; 383(7): 691–3
  7. Kundi H, Balcı MM, Güngörer B, Yeşiltepe M, Coşkun N, Sürel AA. Trends in acute myocardial infarction admissions during the COVID-19 pandemic in Ankara, Turkey. Anatol J Cardiol 2020; 24(2): 81–2
  8. Aktoz M, Altay H, Aslanger E, Atalar E, Aytekin V, Baykan AO, et al. Consensus Report from Turkish Society of Cardiology: COVID-19 and cardiovascular diseases. What cardiologists should know. (25th March 2020)]. Turk Kardiyol Dern Ars 2020; 48(Suppl 1): 1–48
  9. Goha A, Mezue K, Edwards P, Nunura F, Baugh D, Madu E. COVID-19 and the heart: An update for clinicians. Clin Cardiol 2020; 43(11): 1216–22
  10. Gerstein NS, Venkataramani R, Goumas AM, Chapman NN, Deriy L. COVID-19-related cardiovascular disease and practical considerations for perioperative clinicians. Semin Cardiothorac Vasc Anesth 2020; 24(4): 293–303
  11. Bandyopadhyay D, Akhtar T, Hajra A, Gupta M, Das A, Chakraborty S, et al. COVID-19 pandemic: Cardiovascular complications and future implications. Am J Cardiovasc Drugs 2020; 20(4): 311–24
  12. Mahenthiran AK, Mahenthiran AK, Mahenthiran J. Cardiovascular system and COVID-19: Manifestations and therapeutics. Rev Cardiovasc Med 2020; 21(3): 399–409
  13. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr 2020; 14(3): 247–50
  14. Kipshidze N, Dangas G, White CJ, Kipshidze N, Siddiqui F, Lattimer CR, et al. Viral coagulopathy in patients with COVID-19: Treatment and care. Clin Appl Thromb Hemost 2020; 26: 1076029620936776
  15. Miesbach W, Makris M. COVID-19: Coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemos 2020; 26: 1076029620938149 1